Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares dropped 31.9% during mid-day trading on Monday . The stock traded as low as GBX 25 ($0.33) and last traded at GBX 25 ($0.33). Approximately 179,117 shares traded hands during trading, an increase of 140% from the average daily volume of 74,700 shares. The stock had previously closed at GBX 36.70 ($0.49).
Celadon Pharmaceuticals Trading Down 40.0 %
The company has a market capitalization of £15.16 million, a price-to-earnings ratio of -305.83 and a beta of -0.25. The company has a debt-to-equity ratio of 148.29, a quick ratio of 6.97 and a current ratio of 2.62. The firm has a fifty day moving average price of GBX 42.42 and a 200-day moving average price of GBX 72.45.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- Golden Cross Stocks: Pattern, Examples and Charts
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What Are Dividend Champions? How to Invest in the Champions
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
